… SARS-CoV-2 infection with resistance to mutagenic escape. … -existing human scFv repertoires,
reactive to a broad range of … (two monoclonal antibodies, and two two-Ab combination …

… first time that a SARS-CoV-specific human monoclonal antibody, CR3022, could … Human
monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape …

… combination of nMAbs accounting for different specificities may provide a powerful way to
minimize mutational escape by … the S protein could confer a synergistic neutralizing effect. Anti-…

… monoclonal antibodies that target the S glycoprotein of SARS-… escape mutants. These results
pave the way for using S309 and … A synergistic effect between two non-competing anti-RBD …

… , 13 human monoclonal antibodies targeting the SARS-CoV-2 … against resistance due to
virus escape mutants. Besides the … wild-type SARS-CoV-2 virus in a synergistic manner (67). …

… potent neutralizing monoclonal antibodies (mAbs) targeting … combination of CoV2-06 and
CoV2-14 showed a synergy in … Then, antibody alone or in mixture were twofold diluted to cover …

… synergistic effects among RBD mutations lead to enhanced resistance when they are present
in combination… , as well as its epidemic characteristics and immune and vaccine escape. …

… all SARS-CoV-2 variants of concern), and an escape profile that is … be used in combination
with other site I or site IV mAbs to … Data were analysed using MacSynergy II and synergy plots …

… A recent report showed that none of the monoclonal antibodies isolated from SARS-CoV-2 …
Mutations in the virus can lead to escape variants [38]. Multiple strategies and combination …

… monoclonal antibody (mAb) 2G1 from prototypic SARS-CoV-2 … cocktails to maintain coverage
against emerging variants … a synergistic effect to delay the generation of escape variants, …